{"corpus_id":12885091,"paper_sha":"81d445ce8517cdaee4714cd684c5df0c92b46742","doi":"10.4061/2011/624764","arxiv_id":null,"pmid":21766000,"pmcid":"3135047","mag_id":2024822408,"dblp_id":null,"acl_id":null,"title":"Serum Adiponectin Levels in Advanced-Stage Parkinson's Disease Patients","year":2011,"publication_date":"2011-06-16","venue":"Parkinson's Disease","journal":{"name":"Parkinson's Disease","pages":null,"volume":"2011"},"journal_issn":null,"journal_title":null,"publication_types":["JournalArticle"],"pubmed_pub_types":["Journal Article"],"s2_fields_of_study":["Medicine"],"reference_count":32,"citation_count":17,"influential_citation_count":1,"is_open_access":true,"arxiv_categories":null,"arxiv_license":null,"arxiv_journal_ref":null,"mesh_headings":null,"chemicals":null,"comments_corrections":null,"source_flags":5,"s2_open_access_pdf_url":"https://downloads.hindawi.com/journals/pd/2011/624764.pdf","s2_open_access_landing_url":"https://www.semanticscholar.org/paper/81d445ce8517cdaee4714cd684c5df0c92b46742","s2_open_access_license":"CCBY","s2_open_access_status":"GOLD","pmc_open_access_pdf_url":null,"pmc_open_access_landing_url":null,"pmc_open_access_license":null,"pmc_open_access_status":null,"unpaywall_open_access_pdf_url":null,"unpaywall_open_access_landing_url":null,"unpaywall_open_access_license":null,"unpaywall_open_access_status":null,"abstract":"Patients with advanced Parkinson's disease (PD) experience body weight loss and reductions in the most common cardiovascular risk factors. At present, the pathogenetic mechanisms involved have not been elucidated. Increased serum concentrations of adiponectin, which possesses antiatherogenic and anti-inflammatory properties, are associated with a reduction in cardiovascular risk. The objective of this study was to determine adiponectin serum concentrations in PD patients. Thirty PD patients underwent a full nutritional status assessment, including the determination of adiponectin serum concentrations. Mean ± SD adiponectin concentrations were 9.59 ± 5.9 μg/mL (interquartile range: 5.92–12.9 μg/mL). In PD patients, adiponectin serum levels were similar to those in normal-weight, healthy, young subjects and significantly higher than that in an aged-matched group of morbidly obese subjects. Further studies are warranted to establish the role of adiponectin in the management of PD patients.","claims":[{"public_id":"cl_0117b344a31abe9c4d9a1dcd6354e035","status":"active","text":"Mean serum adiponectin concentration in the Parkinson's disease cohort was 9.59 ± 5.9 μg/mL, with an interquartile range of 5.92–12.9 μg/mL.","confidence":0.99,"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/claims/cl_0117b344a31abe9c4d9a1dcd6354e035"},{"public_id":"cl_8ffd7e7650e09d785a8ac6b8a12d6b92","status":"active","text":"Serum adiponectin levels in Parkinson's disease patients were significantly higher than those in age-matched morbidly obese subjects.","confidence":0.95,"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/claims/cl_8ffd7e7650e09d785a8ac6b8a12d6b92"},{"public_id":"cl_d625f6ed9e6c6499ad8d0091fcd5adcb","status":"active","text":"Serum adiponectin levels in Parkinson's disease patients were similar to those in normal-weight, healthy, young subjects.","confidence":0.93,"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/claims/cl_d625f6ed9e6c6499ad8d0091fcd5adcb"}],"concepts":[{"public_id":"co_09db21002c3f530871bc80ba0078136b","status":"active","name":"Parkinson's disease patients","description":"The group of patients with Parkinson's disease examined in the study.","types":["patient cohort"],"aliases":["PD patients"],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_09db21002c3f530871bc80ba0078136b"},{"public_id":"co_19f630e5be011dc4fa0d87ae1523821b","status":"active","name":"aged-matched group of morbidly obese subjects","description":"An age-matched comparison group of subjects with morbid obesity.","types":["comparison group"],"aliases":["age-matched group of morbidly obese subjects"],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_19f630e5be011dc4fa0d87ae1523821b"},{"public_id":"co_21ceb5e45c3cf3b717eabfa1313ecf1a","status":"active","name":"cardiovascular risk factors","description":"Clinical factors associated with increased likelihood of cardiovascular disease.","types":["risk factor"],"aliases":[],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_21ceb5e45c3cf3b717eabfa1313ecf1a"},{"public_id":"co_449b412879157cc4ba09575bf257eec2","status":"active","name":"advanced-stage Parkinson's disease","description":"A later-stage form of Parkinson's disease associated with more severe clinical progression.","types":["condition"],"aliases":["advanced-stage PD","advanced Parkinson's disease","PD"],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_449b412879157cc4ba09575bf257eec2"},{"public_id":"co_6a751b0149b4603ca8ce03460af09fc7","status":"active","name":"anti-inflammatory properties","description":"Biological properties that reduce inflammatory activity.","types":["property"],"aliases":[],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_6a751b0149b4603ca8ce03460af09fc7"},{"public_id":"co_7380354d284fa9121b3a7ef4a317d231","status":"active","name":"antiatherogenic properties","description":"Biological properties that counter the development of atherosclerosis.","types":["property"],"aliases":[],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_7380354d284fa9121b3a7ef4a317d231"},{"public_id":"co_7529312e05c6198bfb45b238cac15d1c","status":"active","name":"normal-weight, healthy, young subjects","description":"A comparison group of healthy younger individuals with normal body weight.","types":["comparison group"],"aliases":[],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_7529312e05c6198bfb45b238cac15d1c"},{"public_id":"co_a2a159fa809fe5e51a1fd2ac39d2472a","status":"active","name":"serum adiponectin concentrations","description":"The amount of adiponectin measured in blood serum.","types":["biomarker"],"aliases":["serum adiponectin levels","adiponectin serum concentrations"],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_a2a159fa809fe5e51a1fd2ac39d2472a"},{"public_id":"co_d98f5bc54504f03b9da82c7c524fdbe1","status":"active","name":"Parkinson's disease cohort","description":"The set of Parkinson's disease patients included in the serum measurement study.","types":["patient cohort"],"aliases":[],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_d98f5bc54504f03b9da82c7c524fdbe1"},{"public_id":"co_fd8e61a5c31fe7ac774298aa488e4194","status":"active","name":"nutritional status assessment","description":"A clinical evaluation of body weight and nutritional condition, including biomarker measurement.","types":["assessment"],"aliases":[],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_fd8e61a5c31fe7ac774298aa488e4194"}],"external_ids":{"DOI":"10.4061/2011/624764","ArXiv":null,"PubMed":21766000,"PubMedCentral":"3135047","MAG":2024822408,"DBLP":null,"ACL":null},"open_access":{"is_open_access":true,"pdf_url":"https://downloads.hindawi.com/journals/pd/2011/624764.pdf","landing_url":"https://www.semanticscholar.org/paper/81d445ce8517cdaee4714cd684c5df0c92b46742","source":"semantic_scholar","pdf_url_source":"semantic_scholar_open_access_pdf","license":"CCBY","status":"GOLD","reason":null},"reference_availability":{"status":"available","references_indexed":true,"full_text_available":false,"full_text_source":null,"count_basis":"semantic_scholar_metadata","extraction_status":"not_applicable","reason":null},"source":{"provider":"episteme2","base_corpus":"semantic_scholar_dump","freshness_mode":"unknown","basis":["semantic_scholar_metadata","postgres_metadata"],"limits":["paper metadata is based on indexed upstream scholarly datasets","claims and concepts are available only for extracted papers","absence of claims or concepts means no extracted graph data is available in this response"],"status":"available","degraded":false,"degraded_reasons":[],"diagnostics":{"status":"available","degraded":false,"degraded_reasons":[],"metadata_status":"available","graph_status":"available","abstract_status":"available"},"source_flags":5},"paper_id":632780,"paper_uid":"ae18b58c-4614-4683-89d4-84e0b612dc19","canonical_identity":{"paper_id":632780,"paper_uid":"ae18b58c-4614-4683-89d4-84e0b612dc19","identity_status":"available","lookup_basis":"semantic_scholar_external_id","compatibility_path":"corpus_id"},"url":"https://sah.borca.ai/papers/12885091"}